Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodological issues in pharmacokinetic-pharmacodynamic modelling

E Bellissant1, V Sébille, G Paintaud

  • 1Laboratoire de Pharmacologie Expérimentale et Clinique, Faculté de Médecine, Rennes, France. Eric.Bellissant@univ-rennes1.fr

Clinical Pharmacokinetics
|September 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetics and exposure-response relationship of trastuzumab and bevacizumab in early-stage breast cancer.

European journal of clinical pharmacology·2021
Same author

Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study.

British journal of anaesthesia·2019
Same author

Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.

Medecine et maladies infectieuses·2018
Same author

Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).

HIV medicine·2017
Same author

Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies.

Journal of cancer research and clinical oncology·2017
Same author

Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose.

Antimicrobial agents and chemotherapy·2017

This study details pharmacokinetic-pharmacodynamic (PK/PD) modeling, covering experimental design, various models, and estimation methods. It addresses common challenges in PK/PD analysis and parameter interpretation.

Area of Science:

  • Pharmacology
  • Biostatistics
  • Drug Development

Background:

  • Pharmacokinetic-pharmacodynamic (PK/PD) modeling integrates drug concentration and effect data.
  • Understanding PK/PD relationships is crucial for optimizing drug therapy and development.

Purpose of the Study:

  • To provide a comprehensive overview of PK/PD modeling, including design, analysis, and interpretation.
  • To discuss various PK/PD models and estimation techniques for different scenarios.
  • To address practical challenges encountered in PK/PD studies.

Main Methods:

  • Review of theoretical and practical aspects of PK/PD study design.
  • Presentation of basic and complex time-dependent pharmacodynamic models.
  • Discussion of individual and population approaches for PK/PD data estimation.

Related Experiment Videos

  • Application of models to real data and critique of results.

    • Main Results:

    • Detailed explanation of experimental designs for PK/PD studies.
    • Introduction to various pharmacodynamic models, including those addressing hysteresis.
    • Coverage of estimation methods for individual and population PK/PD analyses.
    • Identification of common PK/PD modeling problems and potential solutions.

    Conclusions:

    • Effective PK/PD modeling requires careful study design and appropriate model selection.
    • Understanding model limitations and potential issues is key to reliable results.
    • Pharmacodynamic parameters hold significant importance in drug evaluation.